ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Canada announced $67 million through its Life Sciences Fund for five dual-use research projects in Ontario, Alberta, and BC. Edmonton's Applied Pharmaceutical Innovation gets nearly $22 million for antimicrobial supply resilience, while BC's Avivo Biomedical receives just shy of $11 million for blood transfusion and organ transplantation tech. The funding ties into Canada's Defence Industrial Strategy.
Tap to vote and see what everyone thinks.
Summary by ByteBrief